MESABI TRUST — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that MESABI TRUST filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2025 | $98.60M | Apr 24, 2025 |
| FY2025 | Jan 31, 2024 | $22.86M | Apr 24, 2025 |
| FY2023 | Jan 31, 2023 | ($2.17M) | Apr 24, 2023 |
| FY2023 | Oct 31, 2022 | $84.7K | Apr 24, 2023 |
| FY2023 | Jul 31, 2022 | ($4.37M) | Apr 24, 2023 |
| FY2023 | Apr 30, 2022 | $14.20M | Apr 24, 2023 |
| FY2023 | Jan 31, 2022 | $17.95M | Apr 24, 2023 |
| FY2023 | Oct 31, 2021 | $16.36M | Apr 24, 2023 |
| FY2023 | Jul 31, 2021 | $27.74M | Apr 24, 2023 |
| FY2023 | Apr 30, 2021 | $9.40M | Apr 24, 2023 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2025 | $93.27M | Apr 24, 2025 |
| FY2025 | Jan 31, 2024 | $18.98M | Apr 24, 2025 |
| FY2023 | Jan 31, 2023 | ($3.02M) | Apr 24, 2023 |
| FY2023 | Oct 31, 2022 | ($413.7K) | Apr 24, 2023 |
| FY2023 | Jul 31, 2022 | ($4.86M) | Apr 24, 2023 |
| FY2023 | Apr 30, 2022 | $13.60M | Apr 24, 2023 |
| FY2023 | Jan 31, 2022 | $17.44M | Apr 24, 2023 |
| FY2023 | Oct 31, 2021 | $15.99M | Apr 24, 2023 |
| FY2023 | Jul 31, 2021 | $26.76M | Apr 24, 2023 |
| FY2023 | Apr 30, 2021 | $8.57M | Apr 24, 2023 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2025 | $93.94M | Apr 24, 2025 |
| FY2025 | Jan 31, 2024 | $14.61M | Apr 24, 2025 |
| FY2024 | Jan 31, 2023 | $13.86M | Apr 24, 2024 |
| FY2024 | Jan 31, 2022 | $62.84M | Apr 24, 2024 |
| FY2023 | Jan 31, 2021 | $20.81M | Apr 24, 2023 |
| FY2022 | Jan 31, 2020 | $34.59M | Apr 27, 2022 |
| FY2021 | Jan 31, 2019 | $45.50M | Apr 27, 2021 |
| FY2019 | Jan 31, 2018 | $29.51M | Apr 13, 2020 |
| FY2018 | Jan 31, 2017 | $12.58M | Apr 12, 2019 |
| FY2017 | Jan 31, 2016 | $8.22M | Apr 13, 2018 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2025 | $101.73M | Apr 24, 2025 |
| FY2025 | Jan 31, 2024 | $26.69M | Apr 24, 2025 |
| FY2024 | Jan 31, 2023 | $14.12M | Apr 24, 2024 |
| FY2023 | Jan 31, 2022 | $53.91M | Apr 24, 2023 |
| FY2022 | Jan 31, 2021 | $22.93M | Apr 27, 2022 |
| FY2021 | Jan 31, 2020 | $23.65M | Apr 27, 2021 |
| FY2019 | Jan 31, 2019 | $35.45M | Apr 13, 2020 |
| FY2018 | Jan 31, 2018 | $26.22M | Apr 12, 2019 |
| FY2017 | Jan 31, 2017 | $14.25M | Apr 13, 2018 |
| FY2016 | Jan 31, 2016 | $9.82M | Apr 14, 2017 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2025 | $78.40M | Apr 24, 2025 |
| FY2025 | Jan 31, 2024 | $5.72M | Apr 24, 2025 |
| FY2024 | Jan 31, 2023 | $2.68M | Apr 24, 2024 |
| FY2023 | Jan 31, 2022 | $23.12M | Apr 24, 2023 |
| FY2022 | Jan 31, 2021 | $6.45M | Apr 27, 2022 |
| FY2021 | Jan 31, 2020 | $11.82M | Apr 27, 2021 |
| FY2019 | Jan 31, 2019 | $18.65M | Apr 13, 2020 |
| FY2018 | Jan 31, 2018 | $15.62M | Apr 12, 2019 |
| FY2017 | Jan 31, 2017 | $4.04M | Apr 13, 2018 |
| FY2016 | Jan 31, 2016 | $827.8K | Apr 14, 2017 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Jan 31, 2018 | $314.8K | Apr 13, 2018 |
| FY2016 | Jan 31, 2017 | $13.70M | Apr 14, 2017 |
| FY2015 | Jan 31, 2016 | $2.59M | Apr 14, 2016 |
| FY2014 | Jan 31, 2015 | $8.72M | Apr 15, 2015 |
| FY2013 | Jan 31, 2014 | $7.72M | Apr 15, 2014 |
| FY2012 | Jan 31, 2013 | $6.73M | Apr 10, 2013 |
| FY2011 | Jan 31, 2012 | $10.25M | Apr 13, 2012 |
| FY2011 | Jan 31, 2011 | $8.69M | Apr 13, 2012 |
| FY2011 | Jan 31, 2010 | $8.44M | Apr 13, 2012 |
| FY2011 | Jan 31, 2009 | $2.25M | Apr 13, 2012 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2025 | 7 | Apr 24, 2025 |
| FY2025 | Jan 31, 2024 | 1 | Apr 24, 2025 |
| FY2023 | Jan 31, 2023 | 0 | Apr 24, 2023 |
| FY2023 | Oct 31, 2022 | 0 | Apr 24, 2023 |
| FY2023 | Jul 31, 2022 | 0 | Apr 24, 2023 |
| FY2023 | Apr 30, 2022 | 1 | Apr 24, 2023 |
| FY2023 | Jan 31, 2022 | 1 | Apr 24, 2023 |
| FY2023 | Oct 31, 2021 | 1 | Apr 24, 2023 |
| FY2023 | Jul 31, 2021 | 2 | Apr 24, 2023 |
| FY2023 | Apr 30, 2021 | 0 | Apr 24, 2023 |